Intervention
Busulfan
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownDonor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesNCT05327023 · 2022-05-23
RECRUITINGAutologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer PatientsNCT02670109 · 2018-02-01
UNKNOWNUmbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaNCT03096782 · 2017-10-13
COMPLETEDCD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantNCT02061800 · 2013-06-03
UNKNOWNSafety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 InfectionNCT01734850 · 2013-04-01
COMPLETEDCord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesNCT01471067 · 2012-07-13
COMPLETEDCommon conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Acute Biphenotypic Leukemia1Acute Leukemia1Acute Lymphoblastic Leukemia1Acute Lymphoblastic Leukemia (ALL)1Acute Lymphoblastic Leukemia in Remission1Acute Myelogenous Leukemia (AML)1Acute Myeloid Leukemia1Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome1Blood And Marrow Transplantation1Chemotherapy-Related Leukemia1Chronic Lymphocytic Leukemia1Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Chronic Myeloid Leukemia (CML)1Chronic Myelomonocytic Leukemia1Hematologic Neoplasms1Hodgkin Lymphoma1Human Immunodeficiency Virus1Juvenile Myelomonocytic Leukemia (JMML)1Langerhans Cell Histiocytosis1Leukemia1Lymphoma1Lymphoma (Hodgkin's and Non-Hodgkin's)1Minimal Residual Disease1Myelodysplastic Syndrome1
Leading sponsors
Trial status mix
COMPLETED3
UNKNOWN2
RECRUITING1
Phase mix
PHASE25
PHASE14
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.